Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Scientists at the Huntington Medical Research Institutes have developed a method for reproducibly generating tissue-engineered, 3-D tumor models that contain both tumor cells and stromal elements with a microscopic architecture. The team says the models are so tissue-like that they call them tumor histoids.

 Each histoid is a few tenths of a millimeter in diameter. They are formed by spontaneous interaction of two or more cell types during histoid culture without a support matrix. They also can be produced in quantities large enough for moderately high-throughput drug screening, according to the researchers.

 During this week’s podcast team member Dr. Marylou Ingram discusses in detail the process and tissue-engineering techniques the scientists used to create the novel tumor models. She also describes what makes these particular models so unique. In addition, Dr. Ingram goes over the range of potential applications for their tissue-engineered tumor models.

  • Add a comment

  • Click here to Login/Register for free. You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »